SE9900177L - Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus - Google Patents

Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Info

Publication number
SE9900177L
SE9900177L SE9900177A SE9900177A SE9900177L SE 9900177 L SE9900177 L SE 9900177L SE 9900177 A SE9900177 A SE 9900177A SE 9900177 A SE9900177 A SE 9900177A SE 9900177 L SE9900177 L SE 9900177L
Authority
SE
Sweden
Prior art keywords
medicament
manufacture
treatment
formic acid
caused
Prior art date
Application number
SE9900177A
Other languages
English (en)
Other versions
SE9900177D0 (sv
SE513436C2 (sv
Inventor
Astrid Agholme
Original Assignee
Astrid Agholme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20414173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9900177(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrid Agholme filed Critical Astrid Agholme
Priority to SE9900177A priority Critical patent/SE513436C2/sv
Publication of SE9900177D0 publication Critical patent/SE9900177D0/sv
Priority to PCT/SE2000/000088 priority patent/WO2000045808A1/en
Priority to EP00902251A priority patent/EP1143966B1/en
Priority to US09/889,740 priority patent/US6503946B1/en
Priority to ES00902251T priority patent/ES2207486T3/es
Priority to AT00902251T priority patent/ATE249820T1/de
Priority to AU23379/00A priority patent/AU2337900A/en
Priority to DE60005299T priority patent/DE60005299T2/de
Publication of SE9900177L publication Critical patent/SE9900177L/sv
Publication of SE513436C2 publication Critical patent/SE513436C2/sv
Priority to NO20013605A priority patent/NO329470B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9900177A 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus SE513436C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900177A SE513436C2 (sv) 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
DE60005299T DE60005299T2 (de) 1999-01-21 2000-01-18 Zubereitung für warzen
AU23379/00A AU2337900A (en) 1999-01-21 2000-01-18 Preparation for warts
US09/889,740 US6503946B1 (en) 1999-01-21 2000-01-18 Preparation for warts
EP00902251A EP1143966B1 (en) 1999-01-21 2000-01-18 Preparation for warts
PCT/SE2000/000088 WO2000045808A1 (en) 1999-01-21 2000-01-18 Preparation for warts
ES00902251T ES2207486T3 (es) 1999-01-21 2000-01-18 Preparacion para verrugas.
AT00902251T ATE249820T1 (de) 1999-01-21 2000-01-18 Zubereitung für warzen
NO20013605A NO329470B1 (no) 1999-01-21 2001-07-20 Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900177A SE513436C2 (sv) 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Publications (3)

Publication Number Publication Date
SE9900177D0 SE9900177D0 (sv) 1999-01-21
SE9900177L true SE9900177L (sv) 2000-07-22
SE513436C2 SE513436C2 (sv) 2000-09-11

Family

ID=20414173

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900177A SE513436C2 (sv) 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Country Status (9)

Country Link
US (1) US6503946B1 (sv)
EP (1) EP1143966B1 (sv)
AT (1) ATE249820T1 (sv)
AU (1) AU2337900A (sv)
DE (1) DE60005299T2 (sv)
ES (1) ES2207486T3 (sv)
NO (1) NO329470B1 (sv)
SE (1) SE513436C2 (sv)
WO (1) WO2000045808A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
BG106215A (bg) * 2001-12-12 2003-06-30 ПАНЧЕВ Владимир Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му
EP2431030B1 (en) 2010-09-17 2015-11-11 Abbell AB Treatment of fungal infections
EP2460509B1 (en) * 2010-12-06 2017-11-15 Abbex Ab Composition for the treatment of warts
SG11201407544XA (en) * 2012-05-28 2014-12-30 Abbex Ab Composition for treatment of warts
EP2692332B1 (en) * 2012-05-29 2019-08-21 Unigroup ApS Composition for the treatment of callus, corns and psoriasis
FR3018687B1 (fr) * 2014-03-19 2017-04-14 Patrick Lepeytre " composition a base d'acides carboxyliques et son application pour le traitement des hyperkeratoses " -
EP3205340A1 (en) * 2016-02-10 2017-08-16 Winko Beheer B.V. Composition for treating skin disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86573A1 (de) * 1986-09-08 1988-04-05 Chimicasa Gmbh Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen
DE59101214D1 (de) 1991-07-15 1994-04-21 Artesan Pharma Gmbh Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
GB9621990D0 (en) * 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19736265C2 (de) 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen

Also Published As

Publication number Publication date
NO20013605L (no) 2001-09-20
AU2337900A (en) 2000-08-25
DE60005299D1 (de) 2003-10-23
SE9900177D0 (sv) 1999-01-21
WO2000045808A1 (en) 2000-08-10
EP1143966B1 (en) 2003-09-17
NO329470B1 (no) 2010-10-25
ATE249820T1 (de) 2003-10-15
US6503946B1 (en) 2003-01-07
SE513436C2 (sv) 2000-09-11
NO20013605D0 (no) 2001-07-20
DE60005299T2 (de) 2004-07-01
ES2207486T3 (es) 2004-06-01
EP1143966A1 (en) 2001-10-17

Similar Documents

Publication Publication Date Title
HRP20030046B1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
HK1085390A1 (en) Solution for ungual and peri-ungual application and its use in preparation of a medicament treating dermatological diseases
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
DE60232178D1 (de) Vorrichtung zur topischen verabreichung
AP1760A (en) Platinum derivative pharmaceutical formulations.
WO2006082588A3 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
WO2005044226A3 (en) Lipid formulations for spontaneous drug encapsulation
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
ATE541562T1 (de) Ibuprofen-suspension
ATE292453T1 (de) Antivirale arznei
JP2002526407A5 (sv)
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
SE9900177L (sv) Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
SE0002476D0 (sv) New compounds
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
MXPA01007210A (es) Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo.
IT1313553B1 (it) Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Legal Events

Date Code Title Description
NUG Patent has lapsed